Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 7, 2019 - Issue 1
Journal homepage
3,287
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma

Xavier ArmoiryPharmacy Department, University of Lyon, School of Pharmacy (ISPB)/UMR CNRS 5510 MATEIS/Lyon University Hospitals, “Edouard Herriot” Hospital, Lyon, France;Warwick Medical School, University of Warwick, Coventry, UKCorrespondence[email protected]
,
Hans-Martin SpathUniversity Claude Bernard Lyon 1, University of Lyon, EA 4129 P2S (Parcours, Santé, Systémique), Lyon, France
,
Aileen ClarkeWarwick Medical School, University of Warwick, Coventry, UKORCID Iconhttps://orcid.org/0000-0001-8299-3146
ORCID Icon,
Martin ConnockWarwick Medical School, University of Warwick, Coventry, UK
,
Paul SutcliffeWarwick Medical School, University of Warwick, Coventry, UK
&
Claude DussartUniversity Claude Bernard Lyon 1, University of Lyon, EA 4129 P2S (Parcours, Santé, Systémique), Lyon, France
Article: 1648971 | Received 26 Feb 2019, Accepted 22 Jul 2019, Published online: 30 Jul 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.